Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tea tree oil gel versus potassium permanganate for pediatric tungiasis
ACTRN12619001610123Phase 2Not yet recruiting
- Sponsor
- University of Canberra
- Start
- Feb 2020
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Tea tree oil and potassium permanganate in tungiasis (2 arms), sponsored by University of Canberra. Primary endpoint: Proportion of non-viable fleas. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
Tea tree oilpotassium permanganate
03
Conditions
tungiasis
Beyond the preview
Go deeper on ACTRN12619001610123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001610123.